Cargando…
Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
Despite significant efforts, there are currently no approved treatments for COVID-19. However, biotechnological approaches appear to be promising in the treatment of the disease. Accordingly, nucleic acid-based treatments including aptamers and siRNAs are candidates that might be effective in COVID-...
Autores principales: | Khanali, Javad, Azangou-Khyavy, Mohammadreza, Asaadi, Yasaman, Jamalkhah, Monire, Kiani, Jafar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630580/ https://www.ncbi.nlm.nih.gov/pubmed/34858370 http://dx.doi.org/10.3389/fmicb.2021.758948 |
Ejemplares similares
-
MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak
por: Jamalkhah, Monire, et al.
Publicado: (2021) -
CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
por: Azangou-Khyavy, Mohammadreza, et al.
Publicado: (2020) -
JAK/STAT-Dependent Chimeric Antigen Receptor (CAR) Expression: A Design Benefiting From a Dual AND/OR Gate Aiming to Increase Specificity, Reduce Tumor Escape and Affect Tumor Microenvironment
por: Khanali, Javad, et al.
Publicado: (2021) -
Engineering chimeric autoantibody receptor T cells for targeted B cell depletion in multiple sclerosis model: An in-vitro study
por: Sahlolbei, Maryam, et al.
Publicado: (2023) -
Aptamer mediated siRNA delivery
por: Chu, Ted C., et al.
Publicado: (2006)